4-Bromo-6-fluoropyiridine-3-carbonitrile - CAS 1805591-30-3
Catalog: |
BB055390 |
Product Name: |
4-Bromo-6-fluoropyiridine-3-carbonitrile |
CAS: |
1805591-30-3 |
Synonyms: |
4-Bromo-6-fluoronicotinonitrile; 4-bromo-6-fluoropyridine-3-carbonitrile |
IUPAC Name: | 4-bromo-6-fluoropyridine-3-carbonitrile |
Molecular Weight: | 201 |
Molecular Formula: | C6H2BrFN2 |
Canonical SMILES: | C1=C(C(=CN=C1F)C#N)Br |
InChI: | InChI=1S/C6H2BrFN2/c7-5-1-6(8)10-3-4(5)2-9/h1,3H |
InChI Key: | OQWIYQNQXBDNBU-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
FR-2955323-A1 | NOVEL INDAZOLE DERIVATIVES INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME AND USE THEREOF | 20100119 |
WO-2011004132-A1 | Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof | 20090710 |
AU-2010224652-A1 | Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof | 20090319 |
CA-2755660-A1 | Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof | 20090319 |
EP-2408762-A1 | Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof | 20090319 |
FR-2943341-A1 | NOVEL INDAZOLE DERIVATIVES INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME AND USE THEREOF | 20090319 |
JP-2012520859-A | SHP90 inhibitory indazole derivatives, compositions containing them, and uses thereof | 20090319 |
KR-20110128942-A | HSP0 inhibitory indazole derivatives, compositions containing them and uses thereof | 20090319 |
TW-201038553-A | Novel indazole derivatives which inhibit HSP90, compositions containing them and use thereof | 20090319 |
US-2012010241-A1 | Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof | 20090319 |
Complexity: | 164 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 199.93854 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 199.93854 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 36.7Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
Maltotetraose Tridecaacetate
-
[866594-61-8]
(3aS,4R,6aR)-Tetrahydro-4-methoxyfuro[3,4-b]furan-2(3H)-one
-
[1365727-07-6]
6-Methyldi(ondansetron-3-de(1,2-dimethyl-1H-imidazole))
-
[86271-48-9]
5-[Bis(2-hydroxyethyl)amino]-2-pentanone
-
(2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid
-
[1456707-58-6]
(2R,6S)-2,6-Dimethyl-4-((R)-2-methyl-3-(4-(tert-pentyl)phenyl)propyl)morpholine-hydrochloride
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS